BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu CS, Lee TY, Chao HW. Targeting glypican-3 as a new frontier in liver cancer therapy. World J Hepatol 2025; 17(9): 107671 [PMID: 41024885 DOI: 10.4254/wjh.v17.i9.107671]
URL: https://www.wjgnet.com/1948-5182/full/v17/i9/107671.htm
Number Citing Articles
1
Didem Agac Cobanoglu, Samantha Franklin, Yue Hu, Devon J. Boland, Xiaotong Song. CAR Intrinsic Design Pre-Shapes Transcriptional and Metabolic Networks in CAR T CellsMetabolites 2026; 16(1): 52 doi: 10.3390/metabo16010052
2
Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, Shou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, Ying-Cheng Lin, Hui-Fen Liu, Teng-Yu Lee. Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma—A Prospective Comparative StudyJournal of Clinical Medicine 2026; 15(2): 448 doi: 10.3390/jcm15020448
3
Faris Alrumaihi, Reem A. Alromaihi, Vikalp Kumar, Shehwaz Anwar. Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular CarcinomaCurrent Issues in Molecular Biology 2025; 47(12): 1056 doi: 10.3390/cimb47121056
4
Ye-Qin Li, Yuan Liao, Wen Zhang, Guo-Wu Rao, Quan Zheng. Research progress of drugs targeting GPC3 in cancer therapyBioorganic Chemistry 2026; 169: 109383 doi: 10.1016/j.bioorg.2025.109383
5
Sina Nabiyi, Mohammad Heiat, Ehsan Rezaei. Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive reviewCytokine & Growth Factor Reviews 2026; 87: 89 doi: 10.1016/j.cytogfr.2025.12.006